Hemodialysis creatine trial will test exercise combo

Key Takeaways

• This is a trial registration, not a published results paper, so no benefits or harms have been shown yet.
• The study plans to compare creatine monohydrate, intradialytic exercise, and their combined effects over 8 weeks.
• The target population is people with chronic kidney disease undergoing maintenance hemodialysis, a very different group from healthy gym users.
• If completed and reported well, the study could clarify whether creatine adds anything meaningful to supervised dialysis-session exercise.
• Creatine monohydrate remains the most-studied form of creatine, but kidney-disease patients should not self-prescribe based on this listing.

What this study announcement actually tells us

The key point is simple: this is news about a trial being launched, not news that creatine has already been shown to help people on hemodialysis. The ClinicalTrials.gov listing says the study aims to test creatine monohydrate supplementation, an intradialytic exercise programme, and the combination of both in patients with chronic kidney disease (CKD) who undergo maintenance hemodialysis.

According to the registry entry, the investigators plan to evaluate effects on body composition, biochemical parameters, and functional capacity over an 8-week period. They also plan to compare the independent effects of creatine and exercise with the combined effects of doing both together.

That makes this interesting for two reasons. First, people on hemodialysis often face major challenges with muscle mass, strength, fatigue, and day-to-day physical function. Second, creatine is best known in sport and resistance training, but its potential role in clinical populations is still being worked out.

For readers who use creatine for training, this is a reminder that creatine research is expanding beyond the gym. For readers with kidney disease, though, the correct interpretation is cautious: the trial is asking an important question, but it has not answered it yet.

If you want the basics on mainstream creatine use in healthier populations, our creatine guides and creatine dosage calculator cover the standard evidence-based approach.

Why creatine in hemodialysis patients is a meaningful question

People receiving maintenance hemodialysis are not typical supplement users. They often live with reduced physical capacity, altered metabolism, inflammation, and muscle wasting risk. Even modest improvements in strength, mobility, or body composition could matter clinically and practically.

That is why the study's focus on functional capacity is important. In clinical research, a gain is not meaningful just because a lab marker changes. What matters is whether patients can move better, tolerate activity better, or maintain more lean tissue over time.

The exercise side of the study also makes sense. Intradialytic exercise means exercise performed during dialysis sessions, which may improve adherence because treatment time is already scheduled. The question the trial is really asking is whether creatine can add something on top of that structured exercise environment.

In sports nutrition, creatine monohydrate is the most-studied creatine form and is typically used to support high-intensity performance and lean mass gains. Position stands and reviews such as Kreider et al. (2017) show strong evidence for efficacy in appropriate settings. But translating that evidence to CKD patients on dialysis is not automatic.

That distinction matters. A person browsing best creatine rankings or comparing options in our creatine product catalog should understand that evidence from healthy athletes does not by itself establish safety or benefit in advanced kidney disease.

Study design: promising question, but still only a registry entry

From the source material provided, we know the study plans to compare creatine monohydrate supplementation, intradialytic exercise, and the combination over 8 weeks. We also know the outcomes of interest include body composition, biochemical parameters, and functional capacity.

What we do not have from the short registry summary is just as important:

• no reported results
• no effect sizes
• no adverse-event data
• no sample-size details in the supplied text
• no dosing protocol in the supplied text
• no peer-reviewed paper to assess methods in full

Those gaps mean readers should avoid drawing strong conclusions. Trial registrations are valuable because they show what researchers intend to study and can reduce selective reporting later. But they are not the same as completed evidence.

Another limitation is timescale. Eight weeks may be enough to detect some changes in function or body composition, but it is still a relatively short intervention in a medically complex population. If the trial eventually reports positive findings, the next questions would be whether the effects are durable, clinically meaningful, and reproducible in larger groups.

There is also the issue of generalisability. Even if creatine helps some hemodialysis patients under supervised clinical conditions, that would not automatically translate to unsupervised use by everyone with kidney disease. It also would not necessarily change what healthy people should buy from creatine brand reviews or how they should use standard maintenance dosing.

What people should do in practice right now

For most readers, the practical takeaway is restraint. This trial is not a signal to start creatine if you are on hemodialysis without medical approval. Advanced CKD is a high-risk, highly monitored context, and supplement decisions should be made with the treating nephrology team.

For healthy adults, the broader creatine evidence base is much stronger. Mainstream guidance typically centres on 3-5 g/day of creatine monohydrate for maintenance, with an optional loading phase of about 20 g/day split into 4 doses for 5-7 days. Those figures come from the long-standing sports-nutrition literature, not from this dialysis trial.

That difference is crucial. You should not assume the dose, timing, or risk-benefit profile used in healthy trainees applies to a person receiving dialysis. Hemodialysis changes fluid balance, metabolism, and clinical monitoring in ways that make self-experimentation inappropriate.

If you are a healthy consumer trying to choose a product, the safest evidence-based default remains plain creatine monohydrate rather than exotic forms. Our creatine guides, creatine dosage calculator, and best creatine rankings can help with ordinary sports-supplement decisions.

If you have CKD or are on dialysis, the better question is not "Which creatine should I buy?" It is "Does my kidney specialist think creatine fits my care plan?" Until trial results appear, that is the most responsible answer.

How this fits with what creatine research already shows

Creatine monohydrate is one of the best-studied sports supplements in the world, with strong support for improving high-intensity exercise performance and helping increase lean mass when paired with training. Reviews such as Antonio et al. (2021) also address common misconceptions, including confusion about creatine and kidney health in otherwise healthy people.

But it is important to separate two evidence questions:

1. Is creatine generally well studied and effective in healthy or athletic populations? Broadly, yes.
2. Has creatine been proven beneficial for people with chronic kidney disease on hemodialysis? Not by this source, because this source is only a trial registration.

That is why this study is worth watching. It is probing a legitimate clinical hypothesis rather than repeating a settled sports-nutrition question. If creatine can support functional outcomes in a dialysis setting, that would expand the practical relevance of creatine science. If it does not, that result would also be important.

Either way, the study sits at the edge of the evidence base, not in its centre. For readers browsing our creatine product catalog or comparing formulas in creatine brand reviews, the current evidence still supports monohydrate as the reference form. What remains uncertain is whether that familiar supplement can deliver clinically useful benefits in this very specific medical context.

Bottom line for creatine users and CKD patients

The bottom line is that a newly registered study will test whether creatine monohydrate plus intradialytic exercise can improve body composition, biochemical markers, and functional capacity in people with CKD on maintenance hemodialysis over 8 weeks. That is a relevant and potentially valuable research question.

What it is not is proof. No outcome data are reported in the supplied source material, so any claim that creatine helps dialysis patients would go beyond the evidence.

For healthy users, nothing in this listing changes the standard picture: creatine monohydrate remains the most established form, and ordinary evidence-based use is still grounded in the wider literature rather than in this trial. For patients with kidney disease, this study should be seen as a sign that researchers are investigating the question carefully, not as a green light for unsupervised supplementation.

If published results eventually show meaningful improvements without concerning safety signals, this could become one of the more interesting clinical extensions of creatine research. Until then, the honest summary is straightforward: promising idea, important population, no results yet.

What this hemodialysis creatine study does and does not show

• 8 weeks Planned intervention period — From the ClinicalTrials.gov summary provided.
• 3 Main outcome areas — Body composition, biochemical parameters, and functional capacity.
• 3-5 g/day Typical creatine maintenance dose — Mainstream sports-nutrition guidance for healthy adults, not a dialysis recommendation.
• 20 g/day Common loading protocol — Usually split into 4 doses for 5-7 days in healthy adults.

Frequently Asked Questions

Sources & Further Reading

• Kreider et al. (2017), ISSN Position Stand: Safety and Efficacy of Creatine — JISSN
• Antonio et al. (2021), Common questions and misconceptions about creatine supplementation — JISSN